Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 697

1.

Risk in dosing regimens for 25-OH vitamin D supplementation in chronic haemodialysis patients.

Albalate M, de la Piedra C, Ortiz A, Hernández Pérez J, Rubert M, Pérez Garcia R, Zazo P, Nieto L, de Sequera P, Egido J.

Nephron Clin Pract. 2012;121(3-4):c112-9. doi: 10.1159/000345148. Epub 2012 Nov 27.

PMID:
23221739
2.

Vitamin D and skin repair: a prospective, double-blind and placebo controlled study in the healing of leg ulcers.

Burkiewicz CJ, Guadagnin FA, Skare TL, do Nascimento MM, Servin SC, de Souza GD.

Rev Col Bras Cir. 2012 Sep-Oct;39(5):401-7. English, Portuguese.

3.

Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months.

Logan VF, Gray AR, Peddie MC, Harper MJ, Houghton LA.

Br J Nutr. 2013 Mar 28;109(6):1082-8. doi: 10.1017/S0007114512002851. Epub 2012 Jul 11.

PMID:
23168298
4.

High prevalence of vitamin D insufficiency in China: relationship with the levels of parathyroid hormone and markers of bone turnover.

Lu HK, Zhang Z, Ke YH, He JW, Fu WZ, Zhang CQ, Zhang ZL.

PLoS One. 2012;7(11):e47264. doi: 10.1371/journal.pone.0047264. Epub 2012 Nov 8.

5.

Assessing the relationship between vitamin D3 and stratum corneum hydration for the treatment of xerotic skin.

Russell M.

Nutrients. 2012 Sep;4(9):1213-8. doi: 10.3390/nu4091213. Epub 2012 Sep 4.

7.

Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children.

Majak P, Jerzyńska J, Smejda K, Stelmach I, Timler D, Stelmach W.

Ann Allergy Asthma Immunol. 2012 Nov;109(5):329-35. doi: 10.1016/j.anai.2012.08.002. Epub 2012 Aug 22.

PMID:
23062388
8.

Bone mineral density and vitamin D status in Parkinson's disease patients.

van den Bos F, Speelman AD, van Nimwegen M, van der Schouw YT, Backx FJ, Bloem BR, Munneke M, Verhaar HJ.

J Neurol. 2013 Mar;260(3):754-60. doi: 10.1007/s00415-012-6697-x. Epub 2012 Oct 9.

PMID:
23052606
9.

Effects of 25-hydroxyvitamin D3 therapy on bone turnover markers and PTH levels in postmenopausal osteoporotic women treated with alendronate.

Olmos JM, Hernández JL, Llorca J, Nan D, Valero C, González-Macías J.

J Clin Endocrinol Metab. 2012 Dec;97(12):4491-7. doi: 10.1210/jc.2012-2999. Epub 2012 Oct 5.

PMID:
23043189
10.

Impact of vitamin D supplementation during a resistance training intervention on body composition, muscle function, and glucose tolerance in overweight and obese adults.

Carrillo AE, Flynn MG, Pinkston C, Markofski MM, Jiang Y, Donkin SS, Teegarden D.

Clin Nutr. 2013 Jun;32(3):375-81. doi: 10.1016/j.clnu.2012.08.014. Epub 2012 Aug 31.

11.

High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D.

Davidson MB, Duran P, Lee ML, Friedman TC.

Diabetes Care. 2013 Feb;36(2):260-6. doi: 10.2337/dc12-1204. Epub 2012 Oct 1.

12.

Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial.

Murdoch DR, Slow S, Chambers ST, Jennings LC, Stewart AW, Priest PC, Florkowski CM, Livesey JH, Camargo CA, Scragg R.

JAMA. 2012 Oct 3;308(13):1333-9. doi: 10.1001/jama.2012.12505.

PMID:
23032549
13.

Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study.

Ureña-Torres PA, Floege J, Hawley CM, Pedagogos E, Goodman WG, Pétavy F, Reiner M, Raggi P.

Nephrol Dial Transplant. 2013 Jan;28(1):146-52. doi: 10.1093/ndt/gfs356. Epub 2012 Sep 30.

14.

Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial.

Sigrist M, Tang M, Beaulieu M, Espino-Hernandez G, Er L, Djurdjev O, Levin A.

Nephrol Dial Transplant. 2013 Jan;28(1):161-9. doi: 10.1093/ndt/gfs405. Epub 2012 Sep 28.

15.

A 12-week double-blind randomized clinical trial of vitamin D₃ supplementation on body fat mass in healthy overweight and obese women.

Salehpour A, Hosseinpanah F, Shidfar F, Vafa M, Razaghi M, Dehghani S, Hoshiarrad A, Gohari M.

Nutr J. 2012 Sep 22;11:78. doi: 10.1186/1475-2891-11-78.

16.

Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer.

Mondul AM, Weinstein SJ, Virtamo J, Albanes D.

Br J Cancer. 2012 Oct 23;107(9):1589-94. doi: 10.1038/bjc.2012.417. Epub 2012 Sep 18.

17.

Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease.

Bittner V, Wenger NK, Waters DD, DeMicco DA, Messig M, LaRosa JC.

Am Heart J. 2012 Sep;164(3):387-93. doi: 10.1016/j.ahj.2012.06.016. Retraction in: Am Heart J. 2013 Jul;166(1):197.

PMID:
22980306
18.

A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients.

Ahearn TU, Shaukat A, Flanders WD, Rutherford RE, Bostick RM.

Cancer Prev Res (Phila). 2012 Oct;5(10):1247-56. doi: 10.1158/1940-6207.CAPR-12-0292. Epub 2012 Sep 10.

19.

A pilot study of active vitamin D administration and insulin resistance in African American patients undergoing chronic hemodialysis.

Hung AM, Sundell MB, Plotnikova NE, Bian A, Shintani A, Ellis CD, Siew ED, Ikizler TA.

J Ren Nutr. 2013 May;23(3):185-93. doi: 10.1053/j.jrn.2012.06.005. Epub 2012 Sep 7.

20.

Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3.

Gilfraguas L, Guadalix S, Martinez G, Jodar E, Vara J, Gomez-Sanchez MA, Delgado J, De La Cruz J, Lora D, Hawkins F.

Prog Transplant. 2012 Sep;22(3):237-43.

PMID:
22951500
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk